4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0000950170-25-013884
Chief Financial Officer sold 1,254 shares at $3.78 ($4,740)
- Chief Financial Officer acquired 3,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Broadfoot Jill Marie Chief Financial Officer | 2025-02-03 | Option exercise | +3,750 | 33,017 | D | ||
| Broadfoot Jill Marie Chief Financial Officer | 2025-02-04 | Sale | −1,254 | $3.78 | $4,740 | 31,763 | D |
| Derivatives | |||||||
| Broadfoot Jill Marie Chief Financial Officer | 2025-02-03 | Option exercise · Restricted Stock Unit | −3,750 | 3,750 | D | ||
| Open-market sales · 1,254 sh · avg $3.78 · $4,740 | |||||||
Loading xslF345X05/ownership.xml…